Why the study?
Patients with diabetes mellitus have elevated levels of high-sensitivity cardiac troponin, but the diagnostic performance of the ESC 0/1-h and 0/3-h algorithms to rule out or rule in non-ST-elevation myocardial infarction in this group required evaluation.
Does the ESC 0/1-h and 0/3-h algorithm accurately rule out or rule in acute myocardial infarction without ST-elevation in patients with diabetes compared to those without diabetes?
Does the ESC 0/1-h and 0/3-h algorithm accurately rule out or rule in acute myocardial infarction without ST-elevation in patients with diabetes compared to those without diabetes?
The ESC 0/1-h algorithm is safe and performs comparably for ruling out NSTEMI in patients with and without diabetes, whereas the 0/3-h algorithm performs significantly worse in diabetic patients.
Answers are grounded in this paper and cite their sources.
Caution with ESC 0/3-h algorithm in diabetes; leaves open diabetes-specific validation in prospective studies.
OBJECTIVE: Patients with diabetes mellitus (DM) have elevated levels of high-sensitivity cardiac troponin (hs-cTn). We investigated the diagnostic performance of the European Society of Cardiology (ESC) algorithms to rule out or rule in acute myocardial infarction (AMI) without ST-elevation in patients with DM. RESEARCH DESIGN AND METHODS: We prospectively enrolled 3,681 patients with suspected AMI and stratified those by the presence of DM. The ESC 0/1-h and 0/3-h algorithms were used to calculate negative and positive predictive values (NPV, PPV). In addition, alternative cutoffs were calculated and externally validated in 2,895 patients. RESULTS: In total, 563 patients (15.3%) had DM, and 137 (24.3%) of these had AMI. When the ESC 0/1-h algorithm was used, the NPV was comparable in patients with and without DM (absolute difference [AD] -1.50 [95% CI -5.95, 2.96]). In contrast, the ESC 0/3-h algorithm resulted in a significantly lower NPV in patients with DM (AD -2.27 [95% CI -4.47, -0.07]). The diagnostic performance for rule-in of AMI (PPV) was comparable in both groups: 0/1-h (AD 6.59 [95% CI -19.53, 6.35]) and 0/3-h (AD 1.03 [95% CI -7.63, 9.7]). Alternative cutoffs increased the PPV in both algorithms significantly, while improvements in NPV were only subtle. CONCLUSIONS: Application of the ESC 0/1-h algorithm revealed comparable safety to rule out AMI comparing patients with and without DM, while this was not observed with the ESC 0/3-h algorithm. Although alternative cutoffs might be helpful, patients with DM remain a high-risk population in whom identification of AMI is challenging and who require careful clinical evaluation.
No takes yet. Share an insight, caveat, or question.
Haller et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: